- Title
- Updating the 2003 European regulatory requirements for registering disease-modifying drugs to be used in the treatment of rheumatoid arthritis
- Creators - without role
- Josef S Smolen - Medical University of ViennaMaarten Boers - Amsterdam UMC Location VUmcEric C Abadie - Association Française de NormalisationFerdinand C Breedveld - Leiden UniversityPaul Emery - University of LeedsThomas Bardin - Hôpital LariboisièreNiti Goel - Medical University of ViennaDominique J Ethgen - Medical University of ViennaBernard P Avouac - Hôpitaux Universitaires Henri-MondorPatrick Durez - UCLouvainBruno Flamion - Medical University of ViennaAndrea Laslop - Medical University of ViennaPierre Miossec - Hôpital Edouard HerriotSusanne Reiter - Federal Institute for Drugs and Medical DevicesJean-Yves Reginster - University of LiègeTask Force Grp Respect Ethics & Ex
- Publication Details
- Rheumatology (Oxford, England), Vol.50(10), pp.1732-1736
- Publisher
- Oxford University Press
- Identifiers
- 9949613308331
- Academic Unit
- King Saud University
- Language
- English
- Resource Type
- Journal article
Journal article
Updating the 2003 European regulatory requirements for registering disease-modifying drugs to be used in the treatment of rheumatoid arthritis
Rheumatology (Oxford, England), Vol.50(10), pp.1732-1736
01/10/2011
PMID: 21242246
Metrics
1 Record Views